BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29115395)

  • 1. Transforming growth factor β1 promotes migration and invasion in HepG2 cells: Epithelial‑to‑mesenchymal transition via JAK/STAT3 signaling.
    Lin XL; Liu M; Liu Y; Hu H; Pan Y; Zou W; Fan X; Hu X
    Int J Mol Med; 2018 Jan; 41(1):129-136. PubMed ID: 29115395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
    Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration.
    Wang B; Liu T; Wu JC; Luo SZ; Chen R; Lu LG; Xu MY
    Biomed Pharmacother; 2018 Feb; 98():214-221. PubMed ID: 29268242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
    Zhang C; Guo F; Xu G; Ma J; Shao F
    Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
    Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
    Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro.
    Huang C; Yang G; Jiang T; Zhu G; Li H; Qiu Z
    Neoplasma; 2011; 58(5):396-405. PubMed ID: 21744993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dioscin Inhibits the Invasion and Migration of Hepatocellular Carcinoma HepG2 Cells by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition.
    Chen B; Zhou S; Zhan Y; Ke J; Wang K; Liang Q; Hou Y; Zhu P; Ao W; Wei X; Xiao J
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31197076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3 activation mediates epithelial-to-mesenchymal transition in human hepatocellular carcinoma cells.
    Zhang CH; Guo FL; Xu GL; Jia WD; Ge YS
    Hepatogastroenterology; 2014 Jun; 61(132):1082-9. PubMed ID: 26158169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy induces transforming growth factor-β-dependent epithelial-mesenchymal transition in hepatocarcinoma cells through cAMP response element binding signalling.
    Hu S; Wang L; Zhang X; Wu Y; Yang J; Li J
    J Cell Mol Med; 2018 Nov; 22(11):5518-5532. PubMed ID: 30134011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
    Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation.
    Zhao D; Besser AH; Wander SA; Sun J; Zhou W; Wang B; Ince T; Durante MA; Guo W; Mills G; Theodorescu D; Slingerland J
    Oncogene; 2015 Oct; 34(43):5447-59. PubMed ID: 25684140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition.
    Li J; Yang B; Zhou Q; Wu Y; Shang D; Guo Y; Song Z; Zheng Q; Xiong J
    Carcinogenesis; 2013 Jun; 34(6):1343-51. PubMed ID: 23430956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of ALK4 inhibits cell proliferation and migration through the inactivation of JAK/STAT3 signaling pathway in glioma.
    Song C; Fan B; Xiao Z
    Biomed Pharmacother; 2018 Feb; 98():440-445. PubMed ID: 29278854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA AB073614 induces epithelial- mesenchymal transition of colorectal cancer cells via regulating the JAK/STAT3 pathway.
    Xue J; Liao L; Yin F; Kuang H; Zhou X; Wang Y
    Cancer Biomark; 2018; 21(4):849-858. PubMed ID: 29439310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
    Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
    Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-1 Controls the Proliferation and Migration of Liver Sinusoidal Endothelial Cells and Their Interaction With Hepatocarcinoma Cells.
    Manzi M; Bacigalupo ML; Carabias P; Elola MT; Wolfenstein-Todel C; Rabinovich GA; Espelt MV; Troncoso MF
    J Cell Physiol; 2016 Jul; 231(7):1522-33. PubMed ID: 26551914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Rg1 attenuates invasion and migration by inhibiting transforming growth factor-β1-induced epithelial to mesenchymal transition in HepG2 cells.
    Yu M; Yu X; Guo D; Yu B; Li L; Liao Q; Xing R
    Mol Med Rep; 2015 Apr; 11(4):3167-73. PubMed ID: 25515352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TALEN-induced disruption of Nanog expression results in reduced proliferation, invasiveness and migration, increased chemosensitivity and reversal of EMT in HepG2 cells.
    Yu AQ; Ding Y; Li CL; Yang Y; Yan SR; Li DS
    Oncol Rep; 2016 Mar; 35(3):1657-63. PubMed ID: 26676719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silibinin attenuates TGF‑β1‑induced migration and invasion via EMT suppression and is associated with COX‑2 downregulation in bladder transitional cell carcinoma.
    Li F; Sun Y; Jia J; Yang C; Tang X; Jin B; Wang K; Guo P; Ma Z; Chen Y; Wang X; Chang L; He D; Zeng J
    Oncol Rep; 2018 Dec; 40(6):3543-3550. PubMed ID: 30272315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.